Sage Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2025 to a ratio of 4.76, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2025. Average receivable collection period, for the Sage Therapeutics Inc in Jun 30 2025 quarter, has decreased to 77 days, compared to 86 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 416 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 685 to 2663.

What is Receivable Turnover Ratio?
What is Sage Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SAGE Receivables Turnover Ratio	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Receivable Change	145.15 %	2.09 %	-89 %	-33.94 %	-34.11 %
Y / Y Revenue Change	265.84 %	77.97 %	-83.56 %	337.08 %	249.8 %
Receivable Turnover Ratio (TTM)	4.76	4.24	3.71	3.6	3.09
SAGE's Total Ranking	# 2663	# 685	# 2405	# 3055	# 3107
Accounts Receivable average collection period days	77	86	98	101	118
Seq. Receivable Change	127.19 %	17.46 %	-38.58 %	49.56 %	-5.39 %
Seq. Revenue Change	125.13 %	9.73 %	7.96 %	37.17 %	9.52 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 139
Healthcare Sector	# 417
Overall Market	# 2663

Receivable Turnover Ratio Statistics
High	Average	Low
0.95	0.14	-0.11
(Dec 31 2020)		(March 31, 2014)

SAGE Company Profile • Back to SAGE Efficiency Comparisons • Compare SAGE Receivables Turnover Ratio to its Competitors

Financial Statements
Sage Therapeutics Inc 's Accounts Receivable	$ 24 Millions	Visit SAGE's Balance sheet
Sage Therapeutics Inc 's Sales TTM	$ 70 Millions	Visit SAGE's Income Statement
Sources of SAGE's Revenues		Visit SAGE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SAGE's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SAGE's Growth Rates	SAGE's Roa	SAGE's Inventory Turnover Ratio	SAGE's Dividend Comparisons
SAGE's Profitability Ratios	SAGE's Roi	SAGE's Asset Turnover Ratio	SAGE's Dividend Growth
SAGE's Valuation Ratios	SAGE's Roe	SAGE's Financial Strength Ratios	SAGE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
Amedisys Inc	7.93	$ 2,402.365 Millions	$ 303.071 Millions
Axogen inc	7.89	$ 203.270 Millions	$ 25.765 Millions
Alphatec Holdings Inc	7.87	$ 682.414 Millions	$ 86.710 Millions
Sotera Health Company	7.86	$ 1,124.442 Millions	$ 143.044 Millions
Indivior Pharmaceuticals Inc	7.81	$ 2,062.000 Millions	$ 264.000 Millions
Idexx Laboratories Inc	7.79	$ 4,036.809 Millions	$ 518.213 Millions
Sanara Medtech Inc	7.77	$ 96.228 Millions	$ 12.378 Millions
Alpha Teknova Inc	7.77	$ 38.209 Millions	$ 4.918 Millions
Vycor Medical Inc	7.77	$ 1.779 Millions	$ 0.229 Millions
Tactile Systems Technology Inc	7.76	$ 298.295 Millions	$ 38.421 Millions
Adaptimmune Therapeutics Plc	7.76	$ 65.085 Millions	$ 8.385 Millions
Lipella Pharmaceuticals Inc	7.73	$ 0.470 Millions	$ 0.061 Millions
Quest Diagnostics Inc	7.65	$ 10,522.000 Millions	$ 1,375.750 Millions
Rhythm Pharmaceuticals Inc	7.65	$ 156.287 Millions	$ 20.441 Millions
Aveanna Healthcare Holdings Inc	7.63	$ 2,177.672 Millions	$ 285.438 Millions
Nephros Inc	7.61	$ 15.573 Millions	$ 2.047 Millions
Geovax Labs Inc	7.59	$ 6.143 Millions	$ 0.809 Millions
Iridex Corp	7.56	$ 48.646 Millions	$ 6.431 Millions
Regenxbio Inc	7.56	$ 155.782 Millions	$ 20.617 Millions
Personalis Inc	7.55	$ 80.317 Millions	$ 10.635 Millions
Pediatrix Medical Group Inc	7.55	$ 1,940.725 Millions	$ 257.102 Millions
Intuitive Surgical Inc	7.51	$ 9,143.700 Millions	$ 1,217.275 Millions
10x Genomics Inc	7.49	$ 642.568 Millions	$ 85.751 Millions
Star Equity Holdings Inc	7.47	$ 67.390 Millions	$ 9.018 Millions
Aspira Women s Health inc	7.47	$ 8.634 Millions	$ 1.156 Millions
Guardant Health Inc	7.46	$ 828.849 Millions	$ 111.099 Millions
Penumbra Inc	7.45	$ 1,280.152 Millions	$ 171.809 Millions
Arcturus Therapeutics Holdings Inc	7.41	$ 122.122 Millions	$ 16.487 Millions
Omada Health Inc	7.37	$ 61.306 Millions	$ 8.322 Millions
Becton Dickinson And Company	7.35	$ 21,386.000 Millions	$ 2,910.750 Millions

Date modified: 2026-08-29T17:22:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.